Antimicrobial resistance (AMR) is one of the world’s most pressing global health threats and could erode the progress made in the treatment of HIV/AIDS, tuberculosis, malaria, and many other infectious diseases. Although AMR occurs naturally, many interrelated factors, including excessive or inappropriate use of antibiotics, poor control practices, and infection prevention, contribute to its acceleration […]
Archive | AMRRSS feed for this section
Antimicrobial resistance (AMR) occurs when microorganisms develop a resistance to a medicine that was originally intended to disable or kill them. While microbes naturally develop resistance to antimicrobials over time, AMR is accelerated by the overuse and misuse of antimicrobial medicines and non-adherence to treatment regimens. AMR jeopardizes the effectiveness of complex surgeries and procedures […]
This guide aims to help individuals, organizations, and governments develop, establish, and maintain effective multidisciplinary and multisectoral coalitions to combat AMR. This document provides guidance on building and strengthening coalitions to combat AMR through five key elements. It primarily focuses on the creation and establishment of new coalitions; however, these elements are relevant throughout the lifespan of a coalition, and revisiting each periodically may be important as coalitions grow and evolve, expand in scope or wane and need to be revitalized. In addition, the elements of coalition building may not necessarily occur in strict sequential order. Depending on the context and existing systems in place, coalitions may be able to use situational analyses that have already been conducted or utilize an existing active network. In each setting, it is important to understand the needs of the coalition and focus on the elements of this guide that align best with those needs.
SIAPS partners with the University of Namibia to host the third international medicine utilization research symposium
SIAPS provided technical assistance to the University of Namibia-School of Pharmacy (UNAM-SoP) in organizing the third international Medicines Utilisation Research in Africa (MURIA) workshop and symposium in Windhoek, June 26–28, 2017. With the theme of “Medicine utilisation research in Africa, influencing patient care and policy”, the conference highlighted the importance of building the capacity of […]
Antimicrobial resistance (AMR) is one of the world’s most pressing and urgent global health threats— one that could erode the current progress against tuberculosis (TB), malaria, HIV/AIDS, and many other infectious diseases. In conjunction with World Antibiotic Awareness Week (14-20 November), the SIAPS Program has published a technical program update on Combating Antimicrobial Resistance with Stronger Health […]
Antimicrobial resistance (AMR) is one of the world’s most pressing and urgent global health threats— one that could erode the current progress against tuberculosis (TB), malaria, HIV/AIDS, and many other infectious diseases. AMR poses an enormous threat to the safety and feasibility of complex surgeries and procedures like organ transplantation and chemotherapy, but could also make childbirth, minor infections, and hospital stays more perilous. While AMR has emerged as a critical issue at the global level, current efforts to address AMR are insufficient to curb its spread. Immediate, cross-cutting, and multidisciplinary action is required to adequately address the multidimensional drivers of AMR. In the health sector, strengthening the systems through which health services and medicines are provided is a prerequisite to making progress against AMR.
This technical program update discusses how the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, funded by the US Agency for International Development (USAID), is working to address AMR through a health system strengthening approach with interventions spanning the global, regional, national, and local levels.
By Aubrey Clark, Technical Advisor for Pharmaceutical Services, and Mohan P. Joshi, Principal Technical Advisor and Cluster Lead for Pharmaceutical Services On September 21st, global leaders attending this year’s United Nations General Assembly will discuss one of the most pressing global public health threats of our time: antimicrobial resistance (AMR). This AMR meeting is only the […]
Improving Infection Prevention and Control Practices at Health Facilities in Resource-Limited Settings: SIAPS Technical Report
Infection prevention and control (IPC) is essential to reduce the spread of health facility-acquired (nosocomial) infections, including drug-resistant ones.
The USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program’s goal in global technical assistance in IPC is to reduce the development and spread of nosocomial infections and antimicrobial resistance. This contributes to an improved quality of patient care and safety in public health facilities in resource-constrained countries.
This report summarizes key accomplishments and lessons learned in implementing SIAPS’ approach to improving IPC practices in four countries: South Africa, Namibia, Jordan, and Ethiopia. All activities address SIAPS’s overall objective to build or enhance national and facility capacity to develop, implement, and monitor IPC programs by focusing on the principles of health systems strengthening.
Joshi MP. Containing antimicrobial resistance to realize the goals of universal health coverage. Oral presentation at the Ecumenical Pharmaceutical Network (EPN) Forum 2016, Tubingen, Germany. May 18-21, 2016.
Delegates at the Ecumenical Pharmaceutical Network (EPN) Forum 2016, agreed upon and issued a Call to Action against antimicrobial resistance during the biannual meeting, held 18-21 May 2016, in Tubingen, Germany. EPN, a partner of the USAID-funded SIAPS Program, issued the renewed call to action with support from SIAPS and other partners. The Call to […]